CN Patent

CN102458581B — 作为JANUS激酶抑制剂的吡唑-4-基-吡咯并[2，3-d]嘧啶和吡咯-3-基-吡咯并[2，3-d]嘧啶的N-(杂)芳基-吡咯烷衍生物

Assigned to Because Of C1-Esteraseremmer-N Parent Corp · Expires 2016-03-30 · 10y expired

What this patent protects

本发明涉及式I的N-(杂)芳基-吡咯烷衍生物： 其是诸如选择性JAK1抑制剂的JAK抑制剂，其用于治疗JAK-相关疾病，包括例如炎症性和自身免疫性疾病以及癌症。

USPTO Abstract

本发明涉及式I的N-(杂)芳基-吡咯烷衍生物： 其是诸如选择性JAK1抑制剂的JAK抑制剂，其用于治疗JAK-相关疾病，包括例如炎症性和自身免疫性疾病以及癌症。

Drugs covered by this patent

Patent Metadata

Patent number
CN102458581B
Jurisdiction
CN
Classification
—
Expires
2016-03-30
Drug substance claim
No
Drug product claim
No
Assignee
Because Of C1-Esteraseremmer-N Parent Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.